SC
ARNA

Samlyn Capital’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Samlyn Capital’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-365,350
Closed -$21.4M – 117
2013
Q4 		$21.4M Buy
365,350
+138,693
+61% +$7.25M 0.53% 65
2013
Q3 		$11.9M Buy
226,657
+61,744
+37% +$4.15M 0.33% 81
2013
Q2 		$12.7M Buy
+164,913
New +$13.5M 0.37% 82

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Samlyn Capital's ARNA Position: Q1 2014 in Review

Samlyn Capital sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2014, closing a stake of 365,350 shares — an estimated $21.4M sold.

Samlyn Capital first reported a position in ARNA in Q2 2013 and held it in 3 quarters. The position peaked at $21.4M in Q4 2013. 131 funds tracked by Wall St. Rank hold ARNA as of Q1 2014.

  • Samlyn Capital reported no remaining Arena Pharmaceuticals Inc position as of Q1 2014 after selling out during the quarter.
  • Samlyn Capital sold 365,350 Arena Pharmaceuticals Inc shares in Q1 2014, an estimated $21.4M.
  • Samlyn Capital first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 3 quarters.
  • Samlyn Capital's Arena Pharmaceuticals Inc position peaked at $21.4M in Q4 2013.
  • 131 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2014.

Based on Samlyn Capital's 13F filing for Q1 2014, filed 15 May 2014.